substance p has been researched along with Psoriasis in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (12.00) | 18.7374 |
1990's | 21 (42.00) | 18.2507 |
2000's | 10 (20.00) | 29.6817 |
2010's | 9 (18.00) | 24.3611 |
2020's | 4 (8.00) | 2.80 |
Authors | Studies |
---|---|
Di, T; Fu, J; Guo, J; Guo, X; Li, P; Liu, Q; Liu, Y; Meng, Y; Qi, C; Wang, Y; Zhang, L; Zhao, J | 1 |
Chen, H; Ge, W; Huang, Y; Jiang, J; Jin, Z; Kong, Y; Li, F; Li, L; Li, M; Liu, X; Zeng, X; Zhanmu, O | 1 |
Garces, JC; Ingrasci, G; Lipman, ZM; Loayza, E; Maldonado, C; Nattkemper, LA; Yosipovitch, G | 1 |
Di, T; Fu, J; Guo, J; Li, N; Li, P; Meng, Y; Wang, Y; Zhang, L; Zhao, J | 1 |
Dang, NH; Hatano, R; Itoh, T; Kimura, U; Komiya, E; Morimoto, C; Ohnuma, K; Otsuka, H; Suga, Y; Takamori, K; Tominaga, M; Yamada, T; Yamazaki, H | 1 |
Blackcloud, P; Gilmore, ES; Nousari, Y; Pentland, AP; Poligone, B; Ritchlin, CT; Tausk, F; VanBuskirk, J; Vegas, O; Walter, SA | 1 |
Arkless, KL; Aubdool, AA; Brain, SD; Caton, P; Cleary, SJ; Evans, E; Kee, Z; Kodji, X; Pitchford, SC | 1 |
Aschenbeck, KA; Bertin, A; Dykstra, DD; Ericson, ME; Hordinsky, MK; Kavand, S; Kennedy, WR; Panoutsopoulou, IG; Wendelschafer-Crabb, G | 1 |
Reich, A; Szepietowski, JC | 1 |
Amatya, B; Nordlind, K; Wahlgren, CF | 1 |
Alysandratos, KD; Angelidou, A; Asadi, S; Conti, P; Kalogeromitros, D; Kempuraj, D; Leeman, S; Peterson, E; Stavrianeas, N; Tagen, M; Theoharides, TC; Vasiadi, M; Zhang, B | 1 |
Belkadi, A; Diaconu, D; Loyd, CM; Ostrowski, SM; Ward, NL | 1 |
Dawes, SM; Diaconu, D; Gilbert, E; Kavlick, KD; Michaels, KA; Ward, NL | 1 |
Hawro, T; Lesiak, A; Narbutt, J; Olejniczak, I; Sobolewska-Sztychny, D; Sysa-Jedrzejowska, A; Słowik-Kwiatkowska, I | 1 |
Luo, WH; Ouyang, H; Yang, Z | 1 |
Babu, RJ; Kanikkannan, N; Kikwai, L; Singh, M | 1 |
Namazi, MR | 1 |
Griffiths, CE; Kleyn, CE; Saraceno, R; Terenghi, G | 1 |
Lonne-Rahm, S; Nordlind, K; Remröd, C | 1 |
Orda, A; Reich, A; Szepietowski, JC; Wiśnicka, B | 1 |
Narbutt, J; Sysa-Jedrzejowska, A; Wyczółkowska, J; Zalewska, A | 1 |
Brodecka, H; Glinska-Ferenz, M; Glinski, W; Kowalski, D | 1 |
Abraham, A; Raychadauri, SP; Rein, G; Weltman, H | 1 |
Cattaneo, A; Finzi, A; Mozzanica, N; Vignati, G | 1 |
Krogstad, AL; Swanbeck, G; Wallin, BG | 1 |
Farber, EM | 2 |
Farber, EM; Raychaudhuri, SP | 2 |
Berberian, B; Dodd, WA; Ellis, CN; Jarratt, MT; Katz, HI; Krueger, G; Prawer, S; Rex, IH; Sulica, VI; Wolf, JE | 1 |
Calzá, L; Fantini, F; Giannetti, A; Giardino, L; Pincelli, C; Sevignani, C; Zanni, M | 1 |
Aalto, ML; Harvima, I; Horsmanheimo, M; Naukkarinen, A; Paukkonen, K | 1 |
Cattaneo, A; Clerici, M; Ferrario, E; Finzi, AF; Mozzanica, N; Schmitt, E; Trabattoni, D; Vignati, G; Villa, ML | 1 |
Harvima, IT; Harvima, RJ; Horsmanheimo, M; Järvikallio, A; Lakkakorpi, J; Naukkarinen, A | 1 |
Ayliffe, MJ; Gordon, DJ; Holden, CA; Ostlere, LS; Pereira, RS; Rustin, MH | 1 |
Chan, J; Farber, EM; Jiang, WY; Raychauduri, SP; Smoller, BR | 1 |
Farber, EM; Jiang, WY; Raychaudhuri, SP | 2 |
Alexacos, N; Letourneau, R; Pang, X; Singh, LK; Theoharides, TC | 1 |
Hagforsen, E; Michaëlsson, G; Nordlind, K | 1 |
Benassi, L; Fantini, F; Giannetti, A; Lesa, G; Pincelli, C; Romualdi, P; Sevignani, C | 1 |
Cakar, N; Kürkçüoğlu, N | 1 |
Glinska-Ferenz, M; Glinski, W; Pierozynska-Dubowska, M | 1 |
Anand, P; Blank, MA; Bloom, SR; Polak, JM; Sellu, D; Springall, DR | 1 |
Cagnoni, M; Del Bianco, E; Geppetti, P; Marabini, S; Marchesoni, A; Matucci-Cerinic, M; Partsch, G; Tosi, S | 1 |
Farber, EM; Fraki, JE; Nickoloff, BJ; Recht, B | 1 |
Enhamre, A; Goldstein, M; Hammar, H; Johansson, O; Olsson, A | 1 |
Bernstein, JE | 1 |
Farber, EM; Naukkarinen, A; Nickoloff, BJ | 1 |
Rubins, AY; Wekhsler, HM | 1 |
3 review(s) available for substance p and Psoriasis
Article | Year |
---|---|
Vasoactive peptides in the pathogenesis of psoriasis.
Topics: Calcitonin Gene-Related Peptide; Humans; Nerve Growth Factor; Neuropeptide Y; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 2008 |
Paradoxical exacerbation of psoriasis in AIDS: proposed explanations including the potential roles of substance P and gram-negative bacteria.
Topics: Acquired Immunodeficiency Syndrome; Communicable Diseases; Gram-Negative Bacteria; Humans; Psoriasis; Skin Diseases, Bacterial; Substance P | 2004 |
The role of neuropeptides in psoriasis.
Topics: Calcitonin Gene-Related Peptide; Humans; Nerve Growth Factors; Neuropeptides; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 2006 |
5 trial(s) available for substance p and Psoriasis
Article | Year |
---|---|
Neuromodulatory treatment of recalcitrant plaque psoriasis with onabotulinumtoxinA.
Topics: Adult; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Drug Resistance; Female; Humans; Male; Middle Aged; Nerve Fibers; Neurotransmitter Agents; Pilot Projects; Psoriasis; Severity of Illness Index; Skin; Substance P | 2018 |
Responses to intradermal injections of substance P in psoriasis patients with pruritus.
Topics: Adult; Area Under Curve; Case-Control Studies; Double-Blind Method; Female; Histamine; Humans; Injections, Intradermal; Male; Middle Aged; Pruritus; Psoriasis; Severity of Illness Index; Substance P; Time Factors | 2010 |
[Clinical study on effect of zhuhuang granule no. 2 in treating psoriasis with liver-qi stagnancy].
Topics: Adult; Diagnosis, Differential; Drugs, Chinese Herbal; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 2001 |
Axon-reflex-mediated vasodilatation in the psoriatic plaque?
Topics: Adult; Anesthetics; Axons; Erythema; Female; Humans; Indomethacin; Male; Middle Aged; Prostaglandin Antagonists; Prostaglandins; Psoriasis; Regional Blood Flow; Skin; Substance P; Ultraviolet Rays; Vasodilation | 1995 |
A double-blind evaluation of topical capsaicin in pruritic psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Pruritus; Psoriasis; Substance P | 1993 |
42 other study(ies) available for substance p and Psoriasis
Article | Year |
---|---|
Terrestrosin D ameliorates skin lesions in an imiquimod-induced psoriasis-like murine model by inhibiting the interaction between Substance P and Dendritic cells.
Topics: Animals; Cell Proliferation; Cytokines; Dendritic Cells; Disease Models, Animal; Imiquimod; Mice; Mice, Inbred BALB C; Psoriasis; Saponins; Skin; Substance P | 2022 |
Role of Type I Cannabinoid Receptor in Sensory Neurons in Psoriasiform Skin Inflammation and Pruritus.
Topics: Animals; Eczema; Imiquimod; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Pruritus; Psoriasis; Receptors, Cannabinoid; Sensory Receptor Cells; Substance P | 2023 |
Neuroimmune Mediators of Pruritus in Hispanic Scalp Psoriatic Itch.
Topics: Hispanic or Latino; Humans; Pruritus; Psoriasis; Scalp; Substance P | 2023 |
Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1β/IL-23p40 production.
Topics: Animals; Anxiety; Dendritic Cells; Dermatitis; Emotions; Epidermis; Hyperplasia; Imiquimod; Inflammation; Interleukin-12 Subunit p40; Interleukin-1beta; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neurokinin-1 Receptor Antagonists; Neurotransmitter Agents; Nociceptors; Psoriasis; Receptors, Neurokinin-1; Stress, Psychological; Substance P; Up-Regulation | 2020 |
A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antipruritics; Behavior, Animal; Biomarkers; Case-Control Studies; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Female; Genetic Predisposition to Disease; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Phenotype; Pruritus; Psoriasis; Substance P; Time Factors; Up-Regulation; Young Adult | 2017 |
Chronic social stress Ameliorates psoriasiform dermatitis through upregulation of the Hypothalamic-Pituitary-Adrenal axis.
Topics: Adrenal Cortex Hormones; Animals; Calcitonin Gene-Related Peptide; Corticosterone; Dermatitis; Disease Models, Animal; Ganglia, Spinal; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Transgenic; Nerve Growth Factor; Neuropeptides; Pituitary-Adrenal System; Psoriasis; Receptors, Glucocorticoid; RNA, Messenger; Stress, Psychological; Substance P; Transcriptional Activation; Up-Regulation | 2018 |
Sensory nerves mediate spontaneous behaviors in addition to inflammation in a murine model of psoriasis.
Topics: Animals; Calcitonin Gene-Related Peptide; Denervation; Disease Models, Animal; Diterpenes; Imiquimod; Inflammation; Male; Mice; Mice, Inbred C57BL; Psoriasis; Reactive Nitrogen Species; Reactive Oxygen Species; Sensory Receptor Cells; Skin; Substance P; TRPA1 Cation Channel; TRPV Cation Channels | 2019 |
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.
Topics: Calcium; Cytosol; Humans; Immunohistochemistry; Interleukin-33; Interleukins; Mast Cells; Neurokinin-1 Receptor Antagonists; Piperidines; Psoriasis; RNA, Messenger; Skin; Substance P; Vascular Endothelial Growth Factor A | 2010 |
Cutaneous denervation of psoriasiform mouse skin improves acanthosis and inflammation in a sensory neuropeptide-dependent manner.
Topics: Animals; CD11c Antigen; CD4 Lymphocyte Count; Denervation; Disease Models, Animal; Ganglia, Spinal; Interleukin-23; Isoindoles; Keratinocytes; Mice; Neuropeptides; Peptide Fragments; Psoriasis; Receptor Protein-Tyrosine Kinases; Receptor, TIE-2; Receptors, Calcitonin Gene-Related Peptide; Skin; Substance P | 2011 |
Botulinum neurotoxin A decreases infiltrating cutaneous lymphocytes and improves acanthosis in the KC-Tie2 mouse model.
Topics: Acanthosis Nigricans; Animals; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; CD11c Antigen; Lymphocytes; Mice; Psoriasis; Skin; Substance P | 2012 |
Narrow band ultraviolet B irradiations cause alteration in interleukin-31 serum level in psoriatic patients.
Topics: Adult; Brain-Derived Neurotrophic Factor; Calcitonin Gene-Related Peptide; Corticotropin-Releasing Hormone; Female; Humans; Interleukins; Male; Middle Aged; Pruritus; Psoriasis; Skin; Substance P; Surveys and Questionnaires; Ultraviolet Rays; Ultraviolet Therapy | 2013 |
Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Circular Dichroism; Dermatitis, Contact; Drug Stability; Drug Storage; Hydrogen-Ion Concentration; Pharmaceutical Vehicles; Psoriasis; Sodium Chloride; Spectrometry, Mass, Electrospray Ionization; Substance P; Temperature | 2004 |
Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Topics: Adult; Aged; Chronic Disease; Female; Gene Expression Regulation; Humans; Hydrocortisone; Male; Middle Aged; Pain Measurement; Pruritus; Psoriasis; Receptors, Neurokinin-1; Saliva; Skin; Stress, Psychological; Substance P | 2007 |
Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
Topics: Adult; Aged; Aged, 80 and over; Calcitonin Gene-Related Peptide; Case-Control Studies; Female; Humans; Inflammation Mediators; Male; Middle Aged; Neuropeptide Y; Neuropeptides; Psoriasis; Stress, Physiological; Substance P; Vasoactive Intestinal Peptide | 2007 |
Nitric oxide levels in plasma and fibroblast cultures of psoriasis vulgaris patients.
Topics: Adult; Aged; Case-Control Studies; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Female; Fibroblasts; Humans; Male; Mast Cells; Middle Aged; Nitric Oxide; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 2007 |
Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease.
Topics: beta-Endorphin; Capsaicin; Dermatitis, Atopic; Humans; Neuropeptides; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1994 |
Monocyte adhesion to fibronectin in psoriasis.
Topics: Adult; Cell Adhesion; Cells, Cultured; Female; Fibronectins; Humans; Male; Monocytes; Psoriasis; Substance P | 1994 |
Plasma neuropeptide levels in psoriasis.
Topics: Adult; alpha-MSH; beta-Endorphin; Enkephalin, Methionine; Humans; Male; Middle Aged; Neuropeptides; Psoriasis; Substance P | 1994 |
Psychoneuroimmunology and dermatology.
Topics: Dermatology; Female; Humans; Male; Middle Aged; Psoriasis; Psychoneuroimmunology; Stress, Psychological; Substance P | 1993 |
Are sensory nerves essential for the development of psoriatic lesions?
Topics: Aged; Humans; Male; Neurons, Afferent; Psoriasis; Skin; Substance P | 1993 |
Autoradiographic detection of substance P receptors in normal and psoriatic skin.
Topics: Autoradiography; Binding Sites; Humans; Iodine Radioisotopes; Psoriasis; Receptors, Neurokinin-1; Receptors, Neurotransmitter; Skin; Substance P | 1993 |
Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions.
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Cell Adhesion; Female; Humans; Immunohistochemistry; Male; Mast Cells; Middle Aged; Neurons, Afferent; Neuropeptides; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 1993 |
Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients.
Topics: Acute Disease; Adult; Cell Division; Cells, Cultured; Cytokines; Female; Humans; Immunity, Cellular; Interleukin-2; Interleukin-4; Isoantigens; Leukocytes, Mononuclear; Lymphocyte Count; Male; Middle Aged; Phytohemagglutinins; Psoriasis; Substance P; T-Lymphocytes | 1995 |
Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin.
Topics: Adult; Aged; Basement Membrane; Calcitonin Gene-Related Peptide; Female; Histocytochemistry; Humans; Male; Mast Cells; Microscopy, Confocal; Microscopy, Fluorescence; Middle Aged; Peripheral Nerves; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 1996 |
Substance P binding to peripheral blood mononuclear leukocytes in atopic dermatitis.
Topics: Adolescent; Adult; Dermatitis, Atopic; Female; Flow Cytometry; Fluorescein; Fluoresceins; Humans; Lymphocyte Subsets; Lymphocytes; Male; Middle Aged; Phycoerythrin; Protein Binding; Psoriasis; Substance P | 1997 |
Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis.
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Epidermis; Female; Humans; Male; Middle Aged; Nerve Fibers; Psoriasis; Substance P; Vasoactive Intestinal Peptide | 1997 |
Psoriatic keratinocytes express high levels of nerve growth factor.
Topics: Calcitonin Gene-Related Peptide; Humans; Immunoenzyme Techniques; Keratinocytes; Lichen Planus; Nerve Growth Factors; Psoriasis; Skin; Substance P; Up-Regulation | 1998 |
Double-labeled immunofluorescence study of cutaneous nerves in psoriasis.
Topics: Calcitonin Gene-Related Peptide; Fluorescent Antibody Technique, Indirect; Humans; Microtubule-Associated Proteins; Nerve Fibers; Neurons, Afferent; Psoriasis; Skin; Substance P; Vasoactive Intestinal Peptide | 1998 |
Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance P: A link to neurogenic skin disorders.
Topics: Acute Disease; Animals; Antibodies; Capsaicin; Cell Degranulation; Corticotropin-Releasing Hormone; Male; Mast Cells; Microscopy, Electron; Microtomy; Neurogenic Inflammation; Neuroimmunomodulation; Neuropeptides; Neurotensin; Psoriasis; Pyrazoles; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Restraint, Physical; Skin; Stress, Physiological; Substance P; Urticaria | 1999 |
Skin nerve fibres and their contacts with mast cells in patients with palmoplantar pustulosis.
Topics: Adult; Aged; Antigens, Differentiation; Calcitonin Gene-Related Peptide; Cell Count; Female; Humans; Immunohistochemistry; Mast Cells; Middle Aged; Nerve Fibers; Neutrophils; Psoriasis; Skin; Substance P; Sweat Glands; Ubiquitin Thiolesterase | 2000 |
Neuroimmunologic aspects of psoriasis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Biphenyl Compounds; Humans; Immunohistochemistry; Inflammation; Injections, Intralesional; Nerve Growth Factor; Neuroimmunomodulation; Neuropeptides; Peptide T; Psoriasis; Psychoneuroimmunology; Receptors, Nerve Growth Factor; Relaxation Therapy; Skin; Stress, Psychological; Substance P | 2000 |
Substance P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes.
Topics: Cell Division; Cells, Cultured; Humans; Immunohistochemistry; Keratinocytes; Psoriasis; Radioimmunoassay; Substance P; Vasoactive Intestinal Peptide | 1992 |
Substance-P immunoreactivity in active edges of psoriatic plaques.
Topics: Female; Humans; Male; Psoriasis; Skin; Substance P | 1990 |
Neurogenic inflammation induced by capsaicin in patients with psoriasis.
Topics: Administration, Cutaneous; Adult; Age Factors; Capsaicin; Dose-Response Relationship, Drug; Erythema; Forearm; Humans; Inflammation; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1991 |
Neuropeptides in skin disease: increased VIP in eczema and psoriasis but not axillary hyperhidrosis.
Topics: Adult; Axilla; Dermatitis, Atopic; Humans; Hyperhidrosis; Middle Aged; Psoriasis; Regional Blood Flow; Skin; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1991 |
Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis, and psoriatic arthritis synovial fluid.
Topics: Arthritis; Arthritis, Rheumatoid; Humans; Osteoarthritis; Psoriasis; Somatostatin; Substance P; Synovial Fluid | 1991 |
Stress, symmetry, and psoriasis: possible role of neuropeptides.
Topics: Diseases in Twins; Histamine Release; Humans; Lymphocytes; Lymphokines; Mast Cells; Nerve Tissue Proteins; Psoriasis; Skin; Somatostatin; Stress, Physiological; Substance P; Twins, Monozygotic | 1986 |
[The natural course of psoriasis from infancy to adulthood].
Topics: Adolescent; Adult; Child; Child, Preschool; Humans; Infant; Psoriasis; Risk; Stress, Psychological; Substance P | 1987 |
Phenylethanolamine N-methyltransferase-like immunoreactivity in psoriasis. An immunohistochemical study on catecholamine synthesizing enzymes and neuropeptides of the skin.
Topics: Adult; Bombesin; Dopa Decarboxylase; Dopamine beta-Hydroxylase; Female; Humans; Male; Phenylethanolamine N-Methyltransferase; Psoriasis; Skin; Somatostatin; Substance P; Tyrosine 3-Monooxygenase; Vasoactive Intestinal Peptide | 1987 |
Capsaicin in the treatment of dermatologic disease.
Topics: Capsaicin; Herpes Zoster; Humans; Neuralgia; Ointments; Psoriasis; Substance P | 1987 |
Quantification of cutaneous sensory nerves and their substance P content in psoriasis.
Topics: Adult; Biopsy; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neurons, Afferent; Psoriasis; Skin; Substance P | 1989 |
Viral-immunological pathogenesis of psoriasis.
Topics: Humans; Interferon Inducers; Psoriasis; Retroviridae; Substance P; T-Lymphocytes | 1989 |